ABOUT THE SUMMIT
The inaugural, exclusive and invitation-only AI for Longevity Summit, organised by the Longevity AI Consortium at King’s College London, brings together leading scientists, industry players, and experts to present and discuss the cutting-edge of Artificial Intelligence for ageing research and the practical implementation of longevity technologies and therapeutics. To be held at Guy's Hospital campus of King's College London on November 12th, it will be the first in a series of conferences, which we expect to become the world-leading forum of AI for Longevity. The next two events in the series will be held in 2020 in London, UK and Geneva, Switzerland.
MAJOR TOPICS OF THE SUMMIT WILL INCLUDE
Frontier applications of Artificial Intelligence in ageing research, longevity R&D and the development of biomarkers of health and longevity
The paradigm shift from disease treatment and sick care to preventive medicine, and from preventive medicine to precision health, utilising nearly real-time assessment of biomarkers of ageing to coordinate micro-dose interventions to continually rebalance biomarkers of health and longevity and maintain an optimal state of precision health, and how AI will be necessary for the coordination of biomarker monitoring and interventions due to the sheer volume of data
The increasing shift toward actionable biomarkers of ageing, including the identification of biomarkers of health, longevity and ageing that have the highest ratios of accuracy and precision vs. actionability, expense and ease-of-implementation, and the benchmarking of biomarkers that can be used in practice today
Emerging trends and novel paradigms relating to both the creation and application of life data, including the construction of biomarkers of ageing, longevity and health collected on a massive scale from healthy individuals and used in scientifically-backed, quantifiable, tangible and precise ways to preserve and maintain an optimal state of health
The creation of novel forms of biomarkers that are still in the initial R&D phase, including image-recognition and photographic biomarkers of ageing, vocal-recognition based biomarkers of ageing, as well as gait, movement and accelerometer-based biomarkers of ageing
What biomarkers of health and longevity can be used today to assess individual’s personal state of health and track the effectiveness of behavioural, lifestyle and therapeutic interventions, as well as how and where to gain access to the leading longevity diagnostic and prognostic technologies that are just now reaching the threshold of real-world practical application
An overview of how biomarkers of health, longevity and ageing can be used at scale by governments to track, measure and test the efficacy of programs and development plans aiming to increase National Healthy Longevity
Speakers
Richard Siow
Ageing Research at King’s College London
Dmitry Kaminskiy
Longevity.Capital
Alex Zhavoronkov
Insilico Medicine
Lance Kawaguchi
HSBC
.jpeg)
Wen Xiao
Prudential
.jpeg)
Fei Ling Lim
Unilever
.jpg)
Lisa Hollins
NHSx
Sergey Young
Longevity Vision Fund
Eric Kihlstrom
Aging Analytics
Agency
Mario Bordbar
Babylon Health
Reza Razavi
King's College London
Chris Kalafatis
King’s College London and Cognetivity
Jorge Cardoso
King’s College London AI Center
.jpeg)
Neelam Patel
MedCity
.jpg)
Benjamin Swerner
Juvenescence
Craig Rhodes
NVIDIA
Nickolai Vysokov
BrainPatch
Stephen Harridge
King's College London
Ivana Rosenzweig
King’s College London Sleep City
Davide Danovi
King’s College London